Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems

被引:54
作者
Cariappa, R
Wilhite, TR
Parvin, CA
Luchtman-Jones, L
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[3] St Louis Childrens Hosp, St Louis, MO 63178 USA
关键词
bleeding time; collagen/epinephrine cartridge; collagen/ADP cartridge; PFA-100; von Willebrand disease;
D O I
10.1097/00043426-200306000-00009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The bleeding time test is difficult to perform, standardize, and interpret in children. In this study the authors evaluated the sensitivity, specificity, and efficiency of the bleeding time test and the PFA-100 in a series of children referred for possible bleeding problems. Patients and Methods: Between February 2000 and August 2001 patients aged more than 6 months and less than 18 years of age who were referred to the authors' institution for a hemostatic evaluation were included in the study if residual blood was available for testing on the PFA-100 instrument. Fifty-two children had platelet count, prothrombin time, partial thromboplastin time, bleeding time, and PFA-100 testing performed as well as an evaluation by a hematologist. For PFA-100 testing, 52 patients had Col/Epi measurements; adequate sample remained for Col/ADP testing on 32. Additional testing for diagnostic purposes was at the discretion of the treating physician. Results: Use of the Col/Epi cartridge in the PFA-100 instrument offered 100% sensitivity and 97% specificity for detection of qualitative platelet abnormalities, compared with 37% and 88%, respectively, for bleeding time testing. For pediatric patients with von Willebrand disease, the sensitivity was 100% using the Col/Epi cartridge, compared with 17% for the bleeding time test. The sensitivities for combined qualitative platelet defects and von Willebrand disease using the Col/Epi or Col/ADP cartridges were 100% and 87%, respectively, compared with 37% for the bleeding time test. Conclusions: The PFA-100 is a more efficient test; it can replace the bleeding time test as a component of the laboratory evaluation of children with a potential bleeding problem.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 16 条
  • [1] Carcao MD, 1998, BRIT J HAEMATOL, V101, P70
  • [2] Dean JA, 2000, THROMB HAEMOSTASIS, V84, P401
  • [3] Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy:: a review of analytical variables, benefits and limitations
    Favaloro, EJ
    [J]. HAEMOPHILIA, 2001, 7 (02) : 170 - 179
  • [4] Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy:: efficacy of the PFA-100® and vWF:CBA as combined diagnostic strategies
    Favaloro, EJ
    Kershaw, G
    Bukuya, M
    Hertzberg, M
    Koutts, J
    [J]. HAEMOPHILIA, 2001, 7 (02) : 180 - 189
  • [5] Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
    Fressinaud, E
    Veyradier, A
    Truchaud, F
    Martin, I
    Boyer-Neumann, C
    Trossaert, M
    Meyer, D
    [J]. BLOOD, 1998, 91 (04) : 1325 - 1331
  • [6] Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates
    Fressinaud, E
    Veyradier, A
    Sigaud, M
    Boyer-Neumann, C
    Le Boterff, C
    Meyer, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 777 - 783
  • [7] Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis
    Harrison, P
    Robinson, MSC
    Mackie, IJ
    Joseph, J
    McDonald, SJ
    Liesner, R
    Savidge, GF
    Pasi, J
    Machin, SJ
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (01) : 25 - 31
  • [8] Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function
    Kerényi, A
    Schlammadinger, A
    Ajzner, É
    Szegedi, I
    Kiss, C
    Pap, Z
    Boda, Z
    Muszbek, L
    [J]. THROMBOSIS RESEARCH, 1999, 96 (06) : 487 - 492
  • [9] KUNDU S, 1994, CLIN CHEM, V40, P1827
  • [10] KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106